2023-02 – Q4 2022 Reporting
New Zealand authorities approved the protocol with dosing of SER150 or placebo for six months. All clinical centers in Australia and New Zealand ready to initiate screening of patients in…
New Zealand authorities approved the protocol with dosing of SER150 or placebo for six months. All clinical centers in Australia and New Zealand ready to initiate screening of patients in…
Serodus ASA’s Board of Directors has in agreement with our CEO Eva Steiness decided to relieve her for the administrative burden to manage Serodus ASA from her permanent address in…
Download: Presentation AGM 2022 Download: Minutes from General Meeting
SERODUS ASA - Publishes 2021 Annual Report Download it here